Fitzpatrick, Cella, Harper & Scinto
New York, New York OfficeView all offices
1290 Avenue of the Americas
New York, New York
(New York Co.)
|Profile Visibility |
|#40 in weekly profile views out of 8,638 law firms in New York, New York|
|#328 in weekly profile views out of 271,019 total law firms Overall|
|Intellectual Property Law||Patent, Trademark, Copyright and Unfair Competition|
About this office:
Fitzpatrick, Cella, Harper & Scinto has grown to about 175 attorneys practicing all areas of intellectual property law, including patents, trademarks, copyrights, unfair competition, and trade secrets. Our practice covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation, appeals, interferences, alternative dispute resolution, licensing, opinions, corporate transactions and due diligence. We have one of the premier patent litigation practices in the nation, and we also prosecute more than twice as many patents as any other New York-based firm.
Our offices in New York, Washington D.C. and Costa Mesa, California, serve a diverse national and international clientele from Fortune 500 companies to Internet start-ups. Founded in 1971, we have continually kept pace with the complex world of new technologies and the strategies required for protecting knowledge, vision and ideas.
The quality and experience of our attorneys is second to none. In addition to superior legal qualifications, the majority of our attorneys hold scientific degrees and many also have substantial industry experience. Our attorneys also have a long history of pro bono work, as well as active involvement in bar associations and community organizations.
Our clients do business in a wide range of industries including pharmaceuticals, chemicals, energy, biotechnology, computers, information technology, electronics, medical devices, transportation, telecommunications, finance, food and e-Commerce. As new technologies emerge, we work closely with our clients in developing strategies for protecting and enforcing their intellectual property.
Specific Practice & Industry Groups Details:
Statement of Practice Summary:
Litigation, Patent Prosecution, Trademarks, Copyrights, Licensing and Transactions. Unfair Trade Practices, Pharmaceuticals and Chemicals, Biotechnology. Electronics and Computers, e-Commerce and New Media, Nanotechnology, Interferences.
Documents by Lawyers at this office
Supreme Court Hears Oral Argument in Myriad Genetics
Robert H. Fischer,Dennis Gregory,Dana Lau, April 18, 2013
The United States Supreme Court, on April 15, heard oral argument in Association for Molecular Pathology v. Myriad Genetics, No. 12-398. This case is to decide a profoundly important question, namely whether human genes are patent-eligible.
Year Established: 1971
American Express; Amgen; AstraZeneca; Astellas Pharma Inc.; Bausch & Lomb; Bear USA; Bristol-Myers Squibb; Canon Inc; Canon USA; The Clearing House; Conde Nast; Daiichi Sankyo; Eisai; Essilor International S.A.; Frederick Warne & Co., Inc.; Genzyme; GlaxoSmithKline; Honeywell; Hughes Network Systems; IBM; Instinet; Kyowa Hakko Kogyo; Medtronic; Merck; MTV Networks; Novartis; Phillips-Van Heusen; Prudential; Renkitt Benckiser; Rohde & Schwarz; Sanofi-Aventis; Schaeffler Technologies GmbH & Co. KG; S.C. Johnson & Son, Inc.; Sepracor; St. John's University; Tellabs Operations, Inc.; UCB Pharma, Inc.; Warner Chilcott.